Metabolic syndrome and dietary components are associated with coronary artery disease risk score in free-living adults: a cross-sectional study
© Takahashi et al; licensee BioMed Central Ltd. 2011
Received: 29 November 2010
Accepted: 9 May 2011
Published: 9 May 2011
Coronary artery disease (CAD) is among the main causes of death in developed countries, and diet and lifestyle can influence CAD incidence.
To evaluate the association of coronary artery disease risk score with dietary, anthropometric and biochemical components in adults clinically selected for a lifestyle modification program.
362 adults (96 men, 266 women, 53.9 ± 9.4 years) fulfilled the inclusion criteria by presenting all the required data. The Framingham score was calculated and the IV Brazilian Guideline on Dyslipidemia and Prevention of Atherosclerosis was adopted for classification of the CAD risks. Anthropometric assessments included waist circumference (WC), body fat and calculated BMI (kg/m2) and muscle-mass index (MMI kg/m2). Dietary intake was estimated through 24 h dietary recall. Fasting blood was used for biochemical analysis. Metabolic Syndrome (MS) was diagnosed using NCEP-ATPIII (2001) criteria. Logistic regression was used to determine the odds of CAD risks according to the altered components of MS, dietary, anthropometric, and biochemical components.
For a sample with a BMI 28.5 ± 5.0 kg/m2 the association with lower risk (<10% CAD) were lower age (<60 years old), and plasma values of uric acid. The presence of MS within low, intermediary, and high CAD risk categories was 30.8%, 55.5%, and 69.8%, respectively. The independent risk factors associated with CAD risk score was MS and uric acid, and the protective factors were recommended intake of saturated fat and fiber and muscle mass index.
Recommended intake of saturated fat and dietary fiber, together with proper muscle mass, are inversely associated with CAD risk score. On the other hand, the presence of MS and high plasma uric acid are associated with CAD risk score.
Coronary artery disease (CAD) is among the main causes of death in developed countries, and it currently occurs with greater frequency in developing countries, especially among the elderly [1, 2]. The Framingham score was developed to estimate the CAD risk over 10 years and it was validated for people aged up to 75 years [3, 4]. The PRINCEPS (Identification Program of Cardiovascular Risk Level and Increase in Lipid Parameters) study conducted in Spain between 2004 and 2005 with more than 26,500 individuals of both genders above 45 years of age, observed that established CAD prevalence or CAD risk of 36.9% (n = 9829) . This same study found a prevalence of 34.9% (n = 9292) of individuals with CAD risk higher than 20% in 10 years .
CAD risk can be calculated from risk factors and the presence of clinical signs and biochemical abnormalities . The Framingham risk score is often used as an initial evaluation parameter of CAD risk in individuals with countless risk factors, including those with Metabolic Syndrome (MS) .
The MS is a multiple risk factor for cardiovascular disease and is characterized by increased waist circumference, raised triglycerides, reduced HDL cholesterol, elevated blood pressure, and raised plasma glucose [8, 9]. From these, reduced HDL-c and elevated blood pressure are common components of both CAD risk and MS.
Diet and lifestyle can influence CAD incidence . A Mediterranean diet, rich in plant foods in combination with nonsmoking, moderate alcohol consumption, and daily physical activity is associated with a significantly lower mortality rate of CAD and all cause mortality . Some factors related to MS such as dyslipidemia, hyperglycemia, hypertension, obesity and other risk factors like low levels of physical activity and smoking  have already been well established as CAD risk factors. However, most Brazilian studies investigate the association of factors related to lifestyle changes with CAD risk factors only individually [13–16] (e.g., hypertension, diabetes, hypercholesterolemia); but no national study investigated the association between CAD risk (Framingham score) and its direct relationship with dietary components, biochemical and body composition [17, 18].
The aim of this study was to evaluate the association of CAD risk score with anthropometric, biochemical and dietary factors in adults with or without MS who were clinically selected for a lifestyle modification program.
A descriptive cross-sectional study was conducted in a subgroup of participants clinically screened for a lifestyle modification program "Mexa-se Pró-Saúde [Move for Health]", from 2004 to 2007. This program is offered to patients with non-communicable chronic diseases and consists of regular physical exercise and nutritional counseling. The Metabolism, Exercise and Nutrition Center (CeMENutri), conducts this program since 1992, in Botucatu. Botucatu is a city located in the center of Sao Paulo State, about 230 km west of the capital city and has a population of 121,274 in habitants . The inclusion criteria for participants were individuals over the age of 35, of both genders, with at least one of the MS components and/or comorbities, and without metabolic or motor disabilities that would limit physical exercise.
A total of 658 individuals were attended at the program during this period. From those individuals, 362 individuals had CHD data and were studied. The study included 96 men and 266 women, with age of 53.9 ± 9.4 and BMI of 28.5 ± 5.0 kg/m2. Besides gender the individuals were also distributed by age considering 60 years the cutoff for elderly. All had signed a term of informed consent, and the project was approved by the Research Ethics Committee (CEP protocol 3271-2009) of the Botucatu Medical School (FMB), São Paulo State University (UNESP, Brazil).
Clinical Evaluation of Arterial Blood Pressure
Systolic and diastolic arterial blood pressure was evaluated with the individual in the seated position according to the procedures described by the V Brazilian Guidelines on Arterial Hypertension . Values of systolic blood pressure ≥ 130 mm Hg and/or diastolic blood pressure ≥85 mm Hg were considered abnormal.
Blood samples were collected after overnight fasting 10 to 12 hours using a vacuum venous puncture. The individuals were previously instructed to not perform vigorous physical exercise 24 hours and/or not drink alcohol 72 hours before collection. Laboratory analyses of lipid parameters (total cholesterol, fractions and triglycerides), glucose, uric acid, urea, γ-glutamyl transferase (γ-GT), C-reactive protein (CRP), albumin and total proteins were performed within 4 hours after blood collection using the Dry Chemical method (Vitros® system, Johnson & Johnson), at the Clinical Analyses Laboratory of the Teaching Hospital (School of Medicine UNESP) in Botucatu/SP. The non-high density lipoprotein cholesterol (nHDL-c) values were obtained finding the difference between total cholesterol (TC) and high density lipoprotein cholesterol (HDL-c). Concentrations of triglycerides (TG) >150 mg/dL , TC >200 mg/dL , HDL-c <40 mg/dL for men and <50 mg/dL for women , glycemia ≥100 mg/dL  and uric acid (higher quartile) ♂ > 6,5 mg/dL and ♀ > 5 mg/dL) were considered abnormal [24, 25].
Risk of Coronary Artery Disease (CAD)
In order to estimate the Framingham score and calculate CAD risk over 10 years, the classification from the IV Brazilian Guideline on Dyslipidemia and the Prevention of Arteriosclerosis  was adopted. Individuals who reported diabetes mellitus (type 1 or 2) through clinical protocol were included in phase 1 of risk stratification, which is considered a clinical manifestation equivalent to arteriosclerotic disease. Thus, the population with diabetes has a 20% greater risk of presenting cardiovascular events in 10 years. Phase 2 of the stratification considers the risk by estimating Framingham scores, where after adding the points obtained for each variable (gender, age, systolic blood pressure, TC, HDL-C and smoking), the absolute risk percentage in 10 years was calculated, which can be classified as low risk (<10%), intermediate risk (10 to 20%) and high risk (>20%).
Body weight was measured on a platform anthropometric scale (Filizola®) with maximum capacity of 150 kg and precision of 0.1 kg. Height was determined using a portable Seca® stadiometer, with a precision of 0.1 cm . After body weight and height was evaluated, BMI was calculated (weight/height (m)2) and classified .
Waist circumference (WC) was measured at the point midway between the last rib and the iliac crest. All measurements used the Sanny® steel anthropometric tape measure. Values in excess of 102 cm for men and 88 cm for women  were considered elevated.
Bioelectric impedance (Biodynamics®, model 450, USA) was used to determine the percentage of body fat (%BF) and muscle mass (kg). Segal et al (1988) equation was used to calculated the %BF . Values ranging between 15 and 25% and 20 and 35% for men and women, respectively, were considered normal for (%BF) . The percentage of muscle mass (%MM) was obtained using the Janssen et al., (2000) equation  and the muscle mass index (MMI) was calculated as MM (kg)/height2. Individuals were classified as sarcopenic if their values were below 10.75 kg/m2 and 6.75 kg/m2 for men and women, respectively .
Diagnosis of Metabolic Syndrome was made according to the criteria of NCEP-ATP III [24, 25]. The 5 components used were plasma levels of triglyceride, HDL-C and, fasting plasma glucose, systolic and diastolic blood pressure and WC measurements. Metabolic syndrome was diagnosed when 3 or more of these components were abnormal.
The 24 h dietary recall was used to assess food intake . Dietary data obtained in homemade measurements were converted into grams and milliliters to permit chemical analysis of food intake. The centesimal composition of foods present in the records was calculated using NutWin® (2002) software, version 1.5. Foods not found in the software were added from diverse composition tables and food labels [33, 34]. Diet quality was evaluated using the Adapted Healthy Eating Index (HEI)  and evaluated groups were based on portions recommended by the Adapted Food Pyramid .
The descriptive characteristics were presented as mean and standard deviation, applying the ANOVA and Tukey test to compare means. Regression models negative binomial were adjusted to characterize portions intake. The Spearman correlation was used to evaluate the correlation of demographic, anthropometric, dietary, biochemical, systolic and diastolic blood pressure and MS components with the Framingham risk score. Logistic regression was used to determine the probability of high CAD risk score (low+moderate vs high) according to dietary (adjusted for TCV + BMI), and anthropometric components, MS, CRP and uric acid concentration (adjusted for BMI). A value of p < 0.05 was adopted as significant. The SAS program, version 9.1.3, was used for data analysis.
Demographic, anthropometric, dietary and biochemical characteristics of the sample according to CAD risk score classification in free-living adults
52.1 ± 8.9a
59.4 ± 8.1b
56.6 ± 9.9b
28.3 ± 5.1a
28.8 ± 4.6a
29.1 ± 5.0a
% Body Fat
32.4 ± 8.8a
30.3 ± 6.9a
31.9 ± 7.6a
Waist circumference (cm)
94.6 ± 12.3a
100.6 ± 14.0b
100.0 ± 13.2b
Muscle Mass Index (kg/m2)
8.1 ± 1.4a
9.3 ± 1.7b
8.4 ± 1.5a
Total energy intake (kcal)
1538 ± 484a
1600 ± 470a
1920 ± 912b
84.3 ± 13.6a
83.0 ± 11.6a
83.6 ± 16.6a
Carbohydrates (% of energy)
51.6 ± 8.8a
54.3 ± 9.6a
52.5 ± 7.9a
Proteins (% of energy)
18.7 ± 5.1a
19.9 ± 4.3a
18.2 ± 5.8a
Proteins (g/kg weight)
1.0 ± 0.4a
0.9 ± 0.3a
1.0 ± 0.4a
Lipids (% of energy)
29.9 ± 8.7a
27.2 ± 9.5a
29.1 ± 6.1a
SFA (% of energy)
8.3 ± 3.8a
6.2 ± 2.3a
7.2 ± 3.3a
MUFA (% of energy)
9.0 ± 3.7a
8.3 ± 3.8a
8.6 ± 2.5a
PUFA (% of energy)
6.9 ± 3.7a
7.8 ± 4.7a
7.9 ± 3.0a
162.6 ± 103.6a
147.7 ± 70.5a
206.0 ± 140.6a
13.2 ± 7.5a
16.0 ± 8.8a
16.1 ± 9.0a
3.3 ± 1.5a
3.5 ± 1.0a
3.8 ± 1.4a
3.3 ± 3.0a
3.8 ± 3.5a
2.7 ± 3.0a
2.4 ± 2.3a
3.3 ± 2.9a
3.2 ± 4.2a
0.8 ± 1.1a
1.5 ± 1.7b
1.5 ± 2.5b
Dairy Products (portions)
1.8 ± 1.3a
1.5 ± 1.1a
2.0 ± 1.6a
1.8 ± 1.3a
1.8 ± 1.2a
1.8 ± 1.0a
1.7 ± 1.8a
1.9 ± 2.5a
1.8 ± 3.2a
2.4 ± 2.3a
2.2 ± 1.1a
3.1 ± 2.1a
13.5 ± 3.7a
14.2 ± 3.4a
13.7 ± 4.4a
Total cholesterol (mg/dL)
203.8 ± 35.4a
225.7 ± 49.4b
201.3 ± 42.7a
91.7 ± 18.2a
95.4 ± 14.1a
129.4 ± 50.2b
140.8 ± 61.1a
169.8 ± 70.1b
172.7 ± 69.3b
52.7 ± 12.4a
44.8 ± 9.3b
45.7 ± 12.2b
122.9 ± 31.6a
146.8 ± 46.0b
121.0 ± 41.3a
31.9 ± 9.6a
33.4 ± 7.2a
37.4 ± 18.7b
Uric acid (mg/dL)
4.8 ± 1.3a
5.9 ± 1.6b
5.6 ± 1.5b
31.8 ± 22.4a
36.1 ± 18.9a
32.1 ± 19.1a
151.1 ± 35.4a
180.8 ± 46.6b
155.6 ± 44.7a
0.52 ± 0.57a
0.29 ± 0.21b
0.65 ± 0.96a
124.6 ± 15.6a
140.1 ± 16.8b
131.4 ± 16.0c
79.6 ± 8.9a
84.1 ± 8.1b
81.4 ± 6.0b
Significant correlation of demographic, anthropometric, dietary and biochemical data with CAD risk score (p < 0.05)
CAD Risk Score
% energy from Protein
MS (number of components)
Odds ratio for CAD risk score according to anthropometry, diet, MS, CRP and uric acid concentrations
BMI (≥25 vs <25 kg/m2)
Muscle Mass IndexMI2
% Body fat3
CRP (≥1.0 vs <1.0 mg/dL)
Saturated fat acids (<10% vs ≥ 10% TCV)
Dietary fiber (≥ 20 vs < 20g/d)
In general, besides the variables used to calculate CAD risk score, muscle mass and recommended intake of saturated fat and fiber were associated as protective factors, and the presence of metabolic syndrome was associated as risk factor.
As expected , in this study, CAD risk score increased with age and was related to its diagnostic elements, SBP, TC (nHDL-C) and HDL-C. Furthermore, a strong positive influence of MS and its components (WC, glucose and TG) was observed in CAD risk score. From these, blood pressure and HDL-c are less valid due to the fact they are both CAD risk and MS diagnostic elements.
From the logistic regression analyses, individuals with MS presented a fourfold greater probability of high CAD risk score. The same was observed by Wannamethee et al., (2005) , where men with MS presented a relatively significant risk (RR 1.64; 95% CI; 1.26-2.06) for developing CAD compared to individuals without MS.
The association between MS and CAD risk found in this study was similar the one observed in studies conducted in the United States [38, 39] and Europe [40, 41], where they found a 2 to 3 times greater probability for an increase in CAD risk in individuals with MS. A positive correlation was observed of CAD risk score and the number of MS components, that is, the greater the number of MS components the higher the risk of developing CAD.
The hyperuricemia, another component related to MS, has been associated with cardiovascular disease and other pathological processes . Within this context, UA has been assessed as an independent risk factor for cardiovascular disease, but results are controversial [43, 44]. Our study showed that CAD risk score increases with higher concentrations of UA. The ARIC study , in which more than 13,500 individuals, including men and women, participated, did not show any association between hyperuricemia and CAD risk. A recent study  conducted in Austria with more than 80,000 men revealed a strong relationship between UA and risk factors for arteriosclerosis. The contradictory results may be justified by methodological differences, such as individuals with a recent history of cardiopathy, use of medications that can influence biochemical results, different ethnic groups or social-economic status [43, 45].
One possible, yet contested , pathophysiological mechanism of the association between hyperuricemia and CAD could occur by favoring plaque adhesiveness and thus contribute towards atherogenesis and the formation of blood thrombus .
A protective effect of muscle mass (MMI) on CAD risk score was found. It is known that the genesis of sarcopenia is associated with an increase in reactive species of oxygen and oxidative stress , with a defined role in different types of cardiovascular disease . Weinbrenner et al. , studied the relationship between oxidized LDL and other oxidized stress markets with CAD. The authors suggest that the reduction of oxidized LDL, superoxide dismutase and glutathione peroxidase and the increase in oxidized anti-LDL antibodies improves oxidative stress in individuals with CAD.
As in previous studies [52, 53], it was possible here to observe the beneficial effects of the recommended intake of SFA and dietary fiber on coronary risk. Jakobsen et al  found a positive association between SFA intake and CAD risk among men and women under 60 years of age, but not among individuals over 60 years. In our study the age over 60 seems to influence CAD risk.
A study conducted by Hu et al  on types of fat and their relationship to coronary risk underscores the isocaloric replacement of saturated fat with unsaturated fat, which presents a beneficial effect on reducing CAD risk. Our study did not reveal any relationship with mono or polyunsaturated fat. Hu et al.  conducted a study with more than 80,000 women between 34 and 59 years of age and found significant relations between CAD risk and types of fat, underscoring the high intake of saturated fat as a risk for CAD .
Our study observed that the percentage of energy from protein and the intake of meat are correlated to CAD risk. This is probably due to excess protein of animal origin and the consequent excess intake of saturated fat with higher coronary risks. Individuals with the lower CAD risk score had the lowest legume intake. They also had the lowest caloric intake which could lead to a lower amount of food intake, and a lower intake of legumes.
The mechanism by which SFA influences CAD risk would be by activating Toll-Like 4 receptors, which through free fatty acids stimulate the inflammatory response . Studies have demonstrated the role of inflammation in CAD and other complications [58, 59].
The effects of dietary fiber on CAD risk occur through various mechanisms, such as improved lipid standards , reduced blood pressure  and improved insulin sensitivity . Pereira et al  suggest that dietary fiber intake is inversely associated with CAD risk. In this study, the authors indicate a 10 to 30% reduction in coronary risk for every 10g/day of fiber from cereals and fruit . Soluble fiber and its relation to CAD risk has also been shown in several studies [64, 65]. Pietinen et al  found an inverse association of soluble fiber with CAD risk. In this study, we did not identify the main dietary sources and fiber types and their possible relations with CAD risk score. A review identified 9 prospective studies on the relation of dietary fiber with CAD risk . Among the studies, 7 found a negative association of fiber intake with CAD risk, and 2 studies presented controversial results .
In this paper, we studied the role of recommended intake of SFA and dietary fiber on CAD risk score after adjustments for TCV and BMI. The adjustment for total energy intake is used to provide isocaloric conditions for the studied sample . Thus, the existing difference between an individual with TCV of 3000 kcal and another with 1000 kcal would be cancelled, considering only the % of macronutrients. The adjustment for BMI aims at eliminating the effects of adiposity on CAD risk score. Thus, the adjustment for TCV and BMI in the same model aims at annulling excess calories the obese individual may have.
The limitations in this study were the type of study and the food method record. It was a cross-sectional study and some cause/effect relations cannot be proven, only the presence or not of an association between the factors. A single 24-hour dietary recall is based on foods and amounts actually consumed by an individual on one specific day, which has an important limitation for not capture intra-individual variability in food intake. The ideal procedure would be to apply the food method record at least 3 days per week. Furthermore, other limitation was the study sample; a drop-off of 45% could reduce the impact of our results.
Another weak point was related with the muscle mass quantification by BIA in which muscle mass is calculated from lean body mass which is complementary to fat body mass. Then high muscle mass would mean also low fat mass and fat mass is well known as pro-inflammatory and CAD risk factor.
In this study, recommended intake of saturated fats and dietary fiber are, together with greater muscle mass, inversely associated with CAD risk score. On the other hand, the presence of MS and high plasma uric acid are associated with CAD risk score.
Future proposals for intervention should consider lifestyle changes with proper eating habits and physical exercise (including hypertrophic performance).
List of abbreviations
body mass index
Coronary artery disease
National Cholesterol Education Program-Adult Treatment Painel III
Healthy Eating Index TCV: total caloric value
non-high density lipoprotein cholesterol
high density lipoprotein cholesterol
triglycerides. SFA: saturated fatty acid
monounsaturated fat acid
polyunsaturated fatty acid.
Acknowledgements and Funding
CNPq, CAPES and FAPESP for the financial support and GAP (a statistical support of Botucatu School of Medicine) for the statistical analysis.
- Hu FB: Diet and lifestyle influences on risk of coronary heart disease. Curr Atheroscler Rep. 2009, 11: 257-263. 10.1007/s11883-009-0040-8.View ArticlePubMedGoogle Scholar
- Sahyoun NR, Lentzner H, Hoyert D, Robinson KN: Trends in causes of death among the elderly. Aging Trends. 2001, 1-10.Google Scholar
- Anderson KM, Wilson PW, Odell PM, Kannel WB: An updated coronary risk profile. A statement for health professionals. Circulation. 1991, 83: 356-362.View ArticlePubMedGoogle Scholar
- Anderson KM, Odell PM, Wilson PW, Kannel WB: Cardiovascular disease risk profiles. Am Heart J. 1991, 121: 293-298. 10.1016/0002-8703(91)90861-B.View ArticlePubMedGoogle Scholar
- de Rojas FD, De Frutos T, Ponte A, Chacon JM, Vitale GC: Coronary heart disease and dyslipidemia: a cross-sectional evaluation of prevalence, current treatment, and clinical control in a large cohort of Spanish high-risk patients: the PRINCEPS study. Prev Cardiol. 2009, 12: 65-71. 10.1111/j.1751-7141.2008.00022.x.View ArticlePubMedGoogle Scholar
- Melo-Filho J: Multiple risk factor intervention trial (MRFIT). Revista Brasileira de Hipertensão. 1998, 5: 48-52.Google Scholar
- Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC, et al: Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005, 112: 2735-2752. 10.1161/CIRCULATIONAHA.105.169404.View ArticlePubMedGoogle Scholar
- Grundy SM: Metabolic syndrome: a multiplex cardiovascular risk factor. J Clin Endocrinol Metab. 2007, 92: 399-404.View ArticlePubMedGoogle Scholar
- Grundy SM, Brewer HB, Cleeman JI, Smith SC, Lenfant C: Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004, 109: 433-438. 10.1161/01.CIR.0000111245.75752.C6.View ArticlePubMedGoogle Scholar
- Stampfer MJ, Hu FB, Manson JE, Rimm EB, Willett WC: Primary prevention of coronary heart disease in women through diet and lifestyle. N Engl J Med. 2000, 343: 16-22. 10.1056/NEJM200007063430103.View ArticlePubMedGoogle Scholar
- Knoops KT, de Groot LC, Kromhout D, Perrin AE, Moreiras-Varela O, Menotti A, van Staveren WA: Mediterranean diet, lifestyle factors, and 10-year mortality in elderly European men and women: the HALE project. Jama. 2004, 292: 1433-1439. 10.1001/jama.292.12.1433.View ArticlePubMedGoogle Scholar
- Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L: Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004, 364: 937-952. 10.1016/S0140-6736(04)17018-9.View ArticlePubMedGoogle Scholar
- de Oliveira EP, Manda RM, Torezan GA, Corrente JE, Burini RC: Dietary, anthropometric, and biochemical determinants of plasma high-density lipoprotein-cholesterol in free-living adults. Cholesterol. 2011, 2011: 851750-PubMed CentralView ArticlePubMedGoogle Scholar
- Takahashi MM, de Oliveira EP, Moreto F, Portero-McLellan KC, Burini RC: Association of dyslipidemia with intakes of fruit and vegetables and the body fat content of adults clinically selected for a lifestyle modification program. Arch Latinoam Nutr. 2010, 60: 148-154.PubMedGoogle Scholar
- da Conceicao Ferreira CC, Peixoto Mdo R, Barbosa MA, Silveira EA: Prevalence of cardiovascular risk factors in elderly individuals treated in the Brazilian Public Health System in Goiania. Arq Bras Cardiol. 2010, 95: 621-628. 10.1590/S0066-782X2010005000141.View ArticleGoogle Scholar
- Pimentel GD, Portero-McLellan KC, de Oliveira EP, Spada AP, Oshiiwa M, Zemdegs JC, Barbalho SM: Long-term nutrition education reduces several risk factors for type 2 diabetes mellitus in Brazilians with impaired glucose tolerance. Nutr Res. 2010, 30: 186-190. 10.1016/j.nutres.2010.03.003.View ArticlePubMedGoogle Scholar
- Avezum A, Piegas LS, Pereira JC: Risk factors associated with acute myocardial infarction in the Sao Paulo metropolitan region: a developed region in a developing country. Arq Bras Cardiol. 2005, 84: 206-213.View ArticlePubMedGoogle Scholar
- Sanibal E, Torres E, Sanibal C, Mello A, Damasceno N: Associação entre nutrientes da dieta e fatores de risco cardiovascular. Rev Bras Alim Nutr: J Brazilian Soc Food Nutr. 2009, 34: 71-84.View ArticleGoogle Scholar
- IBGE: Instituto Brasileiro de Geografia e Estatística. Estimativas da população residente em municípios brasileiros. Ministério do Planejamento, Orçamento e Estatística, 2006 [acesso em 12 de junho de 2008, disponível em. [http://www.ibge.gov.br/home/estatistica/populacao/estimativa2006/estimativa.shtm]
- V Diretrizes Brasileiras de Hipertensão Arterial. Revista da Sociedade Brasileira de Cardiologia. 2005, 84:
- I Diretriz Brasileira de Diagnóstico e Tratamento da Síndrome Metabólica. Arq Bras Cardiol. 2005, 84 (Suplemento I):
- IV Diretriz Brasileira Sobre Dislipidemias e Prevenção da Aterosclerose, Departamento de Aterosclerose da Sociedade Brasileira de Cardiologia. Arq Bras Cardiol. 2007, 88:
- Diagnosis and classification of diabetes mellitus. Diabetes Care. 2004, 27 (Suppl 1): S5-S10.
- Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). Jama. 2001, 285: 2486-2497. 10.1001/jama.285.19.2486.
- Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002, 106: 3143-3421.
- Heyward VH, Stolarczyk LM: Avaliação da Composição Corporal Aplicada. Barueri: Manole. 2000Google Scholar
- WHO: Report of a joint FAO/WHO Consultation. Preparation and use of food-based Dietary Guidelines. 2002, Geneva: World Health OrganizationGoogle Scholar
- Segal KR, Van Loan M, Fitzgerald PI, Hodgdon JA, Van Itallie TB: Lean body mass estimation by bioelectrical impedance analysis: a four-site cross-validation study. Am J Clin Nutr. 1988, 47: 7-14.PubMedGoogle Scholar
- Bray GA: An approach to the classification and evaluation of obesity. Obesity. Edited by: Bjorntorp P, Brodoff BN. 1992Google Scholar
- Janssen I, Heymsfield SB, Baumgartner RN, Ross R: Estimation of skeletal muscle mass by bioelectrical impedance analysis. J Appl Physiol. 2000, 89: 465-471.PubMedGoogle Scholar
- Janssen I, Baumgartner RN, Ross R, Rosenberg IH, Roubenoff R: Skeletal muscle cutpoints associated with elevated physical disability risk in older men and women. Am J Epidemiol. 2004, 159: 413-421. 10.1093/aje/kwh058.View ArticlePubMedGoogle Scholar
- Fisberg RM, Slater B, Marchioni DML, Martini LA: Inquéritos Alimentares - Métodos e Bases Científicos. Barueri: Manole. 2005Google Scholar
- NEPA/UNICAMP: Tabela brasileira de composição de alimentos. Taco. Versão 1. Campinas. 2004Google Scholar
- Philippi ST: Tabela de Composição de Alimentos: Suporte para decisão nutricional. 2002, São Paulo, 2Google Scholar
- Mota JF, Rinaldi AEM, Pereira AF, Maestá N, Scarpin MM, Burini RC: Adaptation of the healthy eating index to the food guide of the Brazilian population. Rev Nutri. 2008, 21: 545-552. 10.1590/S1415-52732008000500007.View ArticleGoogle Scholar
- Philippi ST, Latterza AR, Cruz ATR, Ribeiro LC: Adapted food pyramid: a guide for a right food choice. Rev Nutri. 1999, 12: 65-80.Google Scholar
- Wannamethee SG, Shaper AG, Lennon L, Morris RW: Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus. Arch Intern Med. 2005, 165: 2644-2650. 10.1001/archinte.165.22.2644.View ArticlePubMedGoogle Scholar
- Ford ES: The metabolic syndrome and mortality from cardiovascular disease and all-causes: findings from the National Health and Nutrition Examination Survey II Mortality Study. Atherosclerosis. 2004, 173: 309-314.View ArticlePubMedGoogle Scholar
- Malik S, Wong ND, Franklin SS, Kamath TV, L'Italien GJ, Pio JR, Williams GR: Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation. 2004, 110: 1245-1250. 10.1161/01.CIR.0000140677.20606.0E.View ArticlePubMedGoogle Scholar
- Dekker JM, Girman C, Rhodes T, Nijpels G, Stehouwer CD, Bouter LM, Heine RJ: Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn Study. Circulation. 2005, 112: 666-673. 10.1161/CIRCULATIONAHA.104.516948.View ArticlePubMedGoogle Scholar
- Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT: The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. Jama. 2002, 288: 2709-2716. 10.1001/jama.288.21.2709.View ArticlePubMedGoogle Scholar
- Coutinho Tde A, Turner ST, Peyser PA, Bielak LF, Sheedy PF, Kullo IJ: Associations of serum uric acid with markers of inflammation, metabolic syndrome, and subclinical coronary atherosclerosis. Am J Hypertens. 2007, 20: 83-89. 10.1016/j.amjhyper.2006.06.015.View ArticlePubMedGoogle Scholar
- Culleton BF, Larson MG, Kannel WB, Levy D: Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med. 1999, 131: 7-13.View ArticlePubMedGoogle Scholar
- Niskanen LK, Laaksonen DE, Nyyssonen K, Alfthan G, Lakka HM, Lakka TA, Salonen JT: Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study. Arch Intern Med. 2004, 164: 1546-1551. 10.1001/archinte.164.14.1546.View ArticlePubMedGoogle Scholar
- Moriarity JT, Folsom AR, Iribarren C, Nieto FJ, Rosamond WD: Serum uric acid and risk of coronary heart disease: Atherosclerosis Risk in Communities (ARIC) Study. Ann Epidemiol. 2000, 10: 136-143. 10.1016/S1047-2797(99)00037-X.View ArticlePubMedGoogle Scholar
- Strasak A, Ruttmann E, Brant L, Kelleher C, Klenk J, Concin H, Diem G, Pfeiffer K, Ulmer H: Serum uric acid and risk of cardiovascular mortality: a prospective long-term study of 83,683 Austrian men. Clin Chem. 2008, 54: 273-284. 10.1373/clinchem.2007.094425.View ArticlePubMedGoogle Scholar
- Darlington L: Platelet adhesiveness in gout. Postgrad Med J. 1973, 49: 4-26.View ArticleGoogle Scholar
- Emmerson B: Atherosclerosis and urate metabolism. Austr NZJ Med. 1979, 9: 451-454.View ArticleGoogle Scholar
- Powers SK, Kavazis AN, DeRuisseau KC: Mechanisms of disuse muscle atrophy: role of oxidative stress. Am J Physiol Regul Integr Comp Physiol. 2005, 288: R337-344.View ArticlePubMedGoogle Scholar
- Dhalla NS, Temsah RM, Netticadan T: Role of oxidative stress in cardiovascular diseases. J Hypertens. 2000, 18: 655-673. 10.1097/00004872-200018060-00002.View ArticlePubMedGoogle Scholar
- Weinbrenner T, Cladellas M, Isabel Covas M, Fito M, Tomas M, Senti M, Bruguera J, Marrugat J: High oxidative stress in patients with stable coronary heart disease. Atherosclerosis. 2003, 168: 99-106. 10.1016/S0021-9150(03)00053-4.View ArticlePubMedGoogle Scholar
- Boniface DR, Tefft ME: Dietary fats and 16-year coronary heart disease mortality in a cohort of men and women in Great Britain. Eur J Clin Nutr. 2002, 56: 786-792. 10.1038/sj.ejcn.1601509.View ArticlePubMedGoogle Scholar
- Esrey KL, Joseph L, Grover SA: Relationship between dietary intake and coronary heart disease mortality: lipid research clinics prevalence follow-up study. J Clin Epidemiol. 1996, 49: 211-216. 10.1016/0895-4356(95)00066-6.View ArticlePubMedGoogle Scholar
- Jakobsen MU, Overvad K, Dyerberg J, Schroll M, Heitmann BL: Dietary Fat and Risk of Coronary Heart Disease: Possible Effect Modification by Gender and Age. Am J Epidemiol. 2004, 160: 141-149. 10.1093/aje/kwh193.View ArticlePubMedGoogle Scholar
- Hu FB, Manson JE, Willett WC: Types of Dietary Fat and Risk of Coronary Heart Disease: A Critical Review. J Am Coll Nutr. 2001, 20: 5-19.View ArticlePubMedGoogle Scholar
- Hu FB, Stampfer MJ, Manson JE, Rimm E, Colditz GA, Rosner BA, Hennekens CH, Willett WC: Dietary fat intake and the risk of coronary heart disease in women. N Engl J Med. 1997, 337: 1491-1499. 10.1056/NEJM199711203372102.View ArticlePubMedGoogle Scholar
- Song MJ, Kim KH, Yoon JM, Kim JB: Activation of Toll-like receptor 4 is associated with insulin resistance in adipocytes. Biochem Biophys Res Commun. 2006, 346: 739-745. 10.1016/j.bbrc.2006.05.170.View ArticlePubMedGoogle Scholar
- Libby P: Inflammation in atherosclerosis. Nature. 2002, 420: 868-874. 10.1038/nature01323.View ArticlePubMedGoogle Scholar
- Libby P, Ridker PM, Maseri A: Inflammation and atherosclerosis. Circulation. 2002, 105: 1135-1143. 10.1161/hc0902.104353.View ArticlePubMedGoogle Scholar
- Jenkins DJA, Kendall CWC, Vuksan V, et al: Soluble fiber intake at a dose approved by the US Food and Drug Administration for a claim of health benefits: serum lipid risk factors for cardiovascular disease assessed in a randomized controlled crossover trial. Am J Clin Nutr. 2002, 75: 834-839.PubMedGoogle Scholar
- Vuksan V, Jenkins DJ, Spadafora P, et al: Konjac-mannan (glucomannan) improves glycemia and other associated risk factors for coronary heart disease in type 2 diabetes: a randomized controlled metabolic trial. Diabetes Care. 1999, 22: 913-919. 10.2337/diacare.22.6.913.View ArticlePubMedGoogle Scholar
- Pereira MA, Jacobs DJ, Pins JJ: The effect of whole grains on insulin sensitivity in overweight hyperinsulinemic adults. Am J Clin Nutr. 2002, 75: 848-855.PubMedGoogle Scholar
- Pereira MA, O'Reilly E, Augustsson K, et al: Dietary Fiber and Risk of Coronary Heart Disease. A Pooled Analysis of Cohort Studies. Arch Intern Med. 2004, 164: 370-376. 10.1001/archinte.164.4.370.View ArticlePubMedGoogle Scholar
- Rimm EB, Ascherio A, Giovannucci E, Spiegleman D, Stampfer MJ, Willett WC: Vegetable, fruit, and cereal fiber intake and risk of coronary heart disease among men. JAMA. 1996, 275: 447-451. 10.1001/jama.275.6.447.View ArticlePubMedGoogle Scholar
- Liu S, Buring JE, Sesso HD, Rimm EB, Willett WC, Manson JE: A prospective study of dietary fiber intake and risk of cardiovascular disease among women. J Am Coll Cardiol. 2002, 39: 49-56.View ArticlePubMedGoogle Scholar
- Pietinen P, Rimm EB, Korhonen P, et al: Intake of dietary fiber and risk of coronary heart disease in a cohort of Finnish men: the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Circulation. 1996, 94: 2720-2727.View ArticlePubMedGoogle Scholar
- Kushi LH, Meyer KA, Jacobs DR: Cereals, legumes, and chronic disease risk reduction: evidence from epidemiologic studies. Am J Clin Nutr. 1999, 70: 451S-458S.PubMedGoogle Scholar
- Willett WC, Howe GR, Kushi LH: Adjustment for total energy intake in epidemiologica studies. Am J Clin Nutr. 1997, 65 (supl l): S1220-S1228.Google Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.